These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 10718778

  • 1. Pharmacokinetics and pharmacodynamics of sibrafiban alone or in combination with ticlopidine and aspirin.
    Wittke B, Ensor H, Chung J, Birnböck H, Lausecker B, Ertel SI, MacKie IJ, Machin SJ.
    Br J Clin Pharmacol; 2000 Mar; 49(3):231-9. PubMed ID: 10718778
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics and pharmacodynamics of Ro 44-3888 after single ascending oral doses of sibrafiban, an oral platelet aggregation inhibitor, in healthy male volunteers.
    Wittke B, Mackie IJ, Machin SJ, Timm U, Zell M, Goggin T.
    Br J Clin Pharmacol; 1999 May; 47(5):521-30. PubMed ID: 10336576
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and pharmacodynamics of sibrafiban, an orally administered GP IIb/IIIa antagonist, following coadministration of aspirin and heparin.
    Reimann JD, Modi NB, Novotny W.
    J Clin Pharmacol; 2000 May; 40(5):488-95. PubMed ID: 10806602
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and pharmacodynamics of sibrafiban, an orally administered IIb/IIIa antagonist, in patients with acute coronary syndrome.
    Modi NB, Novotny W, Reimann JD, Cannon CP, Braunwauld E.
    J Clin Pharmacol; 1999 Jul; 39(7):675-84. PubMed ID: 10392322
    [Abstract] [Full Text] [Related]

  • 7. Sibrafiban.
    Dooley M, Goa KL.
    Drugs; 1999 Feb; 57(2):225-30; discussion 231-2. PubMed ID: 10188763
    [Abstract] [Full Text] [Related]

  • 8. Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial. The SYMPHONY Investigators. Sibrafiban versus Aspirin to Yield Maximum Protection from Ischemic Heart Events Post-acute Coronary Syndromes.
    Lancet; 2000 Jan 29; 355(9201):337-45. PubMed ID: 10665552
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dose-dependent inhibition of human platelet aggregation by prasugrel and its interaction with aspirin in healthy subjects.
    Jakubowski JA, Payne CD, Weerakkody GJ, Brandt JT, Farid NA, Li YG, Naganuma H, Lachno DR, Winters KJ.
    J Cardiovasc Pharmacol; 2007 Mar 29; 49(3):167-73. PubMed ID: 17414229
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effects of laropiprant on the antiplatelet activity of co-administered clopidogrel and aspirin.
    De Kam PJ, Luo WL, Wenning L, Ratcliffe L, Sisk CM, Royalty J, Radziszewski W, Wagner JA, Lai E.
    Platelets; 2014 Mar 29; 25(7):480-7. PubMed ID: 24206527
    [Abstract] [Full Text] [Related]

  • 16. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
    Kobune K, Inoue M, Morikawa M, Tsuboi M, Takanami Y, Iwane Y, Kudo T.
    Res Commun Chem Pathol Pharmacol; 1991 Nov 29; 74(2):153-65. PubMed ID: 1811279
    [Abstract] [Full Text] [Related]

  • 17. [Clinical evaluation of platelet antagonists on the ex vivo inhibitory effects of platelet aggregation].
    Sakata T, Kobayashi K, Katayama Y, Takada T, Matsuyama T.
    Rinsho Byori; 1991 Mar 29; 39(3):315-20. PubMed ID: 2051607
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: an open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy Korean male volunteers.
    Kim TE, Kim BH, Kim J, Kim KP, Yi S, Shin HS, Lee YO, Lee KH, Shin SG, Jang IJ, Yu KS.
    Clin Ther; 2009 Oct 29; 31(10):2249-57. PubMed ID: 19922896
    [Abstract] [Full Text] [Related]

  • 19. Effect of ranitidine on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel.
    Small DS, Farid NA, Li YG, Ernest CS, Payne CD, Salazar DE, Winters KJ.
    Curr Med Res Opin; 2008 Aug 29; 24(8):2251-7. PubMed ID: 18786302
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics and effect of ticlopidine on platelet aggregation in subjects with normal and impaired renal function.
    Buur T, Larsson R, Berglund U, Donat F, Tronquet C.
    J Clin Pharmacol; 1997 Feb 29; 37(2):108-15. PubMed ID: 9055136
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.